Key result
mRNA COVID-19 vaccination was associated with a 2.35-fold increased rate of myocarditis compared to unvaccinated persons, though true rates may be higher due to underreporting of mild or subclinical cases.
Why the study?
Existing estimates of post-vaccination myocarditis and pericarditis rely on symptomatic cases, potentially underreporting asymptomatic cases that can cause long-term damage or sudden death.
Does mRNA COVID-19 vaccination increase the risk of underreported myocarditis in adolescents and young men?
Does mRNA COVID-19 vaccination increase the risk of underreported myocarditis in adolescents and young men?
The review highlights the potential underdiagnosis of mRNA vaccine-induced myocarditis in young men and advocates for proactive screening using MRI and ECG to determine true safety rates.
Answers are grounded in this paper and cite their sources.
Supports vigilance for myocarditis after mRNA vaccination; leaves open causality and true incidence.
SARS-CoV-2 has led to a global pandemic that resulted in a mass vaccination program in many western countries to combat the spread and severity of the illness caused by the virus. Recent studies have shown that myocarditis and pericarditis are rarely occurring side effects caused by some of the vaccines. There have been various studies that have tried to analyze how often it occured. These estimates are driven by symptomatic cases [1], though myocarditis is known to be underreported due to lack of (severe) symptoms, while it may leave long-term damage even when asymptomatic [2]. It is also one of the most common causes of sudden death in young adults. [3]
No takes yet. Share an insight, caveat, or question.
Paz Azakarian (2021) conducted a review in Myocarditis. mRNA COVID-19 vaccine vs. Unvaccinated persons was evaluated on Myocarditis incidence 30 days after the second vaccine dose (RR 2.35, 95% CI 1.10 to 5.02). mRNA COVID-19 vaccination was associated with a 2.35-fold increased rate of myocarditis compared to unvaccinated persons, though true rates may be higher due to underreporting of mild or subclinical cases.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: